263 related articles for article (PubMed ID: 27402815)
21. Genetic aberrations leading to MAPK pathway activation mediate oncogene-induced senescence in sporadic pilocytic astrocytomas.
Jacob K; Quang-Khuong DA; Jones DT; Witt H; Lambert S; Albrecht S; Witt O; Vezina C; Shirinian M; Faury D; Garami M; Hauser P; Klekner A; Bognar L; Farmer JP; Montes JL; Atkinson J; Hawkins C; Korshunov A; Collins VP; Pfister SM; Tabori U; Jabado N
Clin Cancer Res; 2011 Jul; 17(14):4650-60. PubMed ID: 21610151
[TBL] [Abstract][Full Text] [Related]
22. Could changes in the regulation of the PI3K/PKB/Akt signaling pathway and cell cycle be involved in astrocytic tumor pathogenesis and progression?
Hlobilkova A; Ehrmann J; Sedlakova E; Krejci V; Knizetova P; Fiuraskova M; Kala M; Kalita O; Kolar Z
Neoplasma; 2007; 54(4):334-41. PubMed ID: 17822324
[TBL] [Abstract][Full Text] [Related]
23. Knockdown of STAT3 expression by RNAi induces apoptosis in astrocytoma cells.
Konnikova L; Kotecki M; Kruger MM; Cochran BH
BMC Cancer; 2003 Sep; 3():23. PubMed ID: 13678425
[TBL] [Abstract][Full Text] [Related]
24. Functional characterization and potential therapeutic avenues for variants in the NTRK2 gene causing developmental and epileptic encephalopathies.
Long A; Crouse A; Kesterson RA; Might M; Wallis D
Am J Med Genet B Neuropsychiatr Genet; 2022 Jan; 189(1-2):37-47. PubMed ID: 34889524
[TBL] [Abstract][Full Text] [Related]
25. Receptor tyrosine kinase expression in astrocytic lesions: similar features in gliosis and glioma.
Kristt DA; Reedy E; Yarden Y
Neurosurgery; 1993 Jul; 33(1):106-15. PubMed ID: 7689190
[TBL] [Abstract][Full Text] [Related]
26. BDNF, via truncated TrkB receptor, modulates GlyT1 and GlyT2 in astrocytes.
Aroeira RI; Sebastião AM; Valente CA
Glia; 2015 Dec; 63(12):2181-97. PubMed ID: 26200505
[TBL] [Abstract][Full Text] [Related]
27. The MBNL1/circNTRK2/PAX5 pathway regulates aerobic glycolysis in glioblastoma cells by encoding a novel protein NTRK2-243aa.
Zhao Y; Song J; Dong W; Liu X; Yang C; Wang D; Xue Y; Ruan X; Liu L; Wang P; Zhang M; Liu Y
Cell Death Dis; 2022 Sep; 13(9):767. PubMed ID: 36064939
[TBL] [Abstract][Full Text] [Related]
28. Induction of metastatic potential by TrkB via activation of IL6/JAK2/STAT3 and PI3K/AKT signaling in breast cancer.
Kim MS; Lee WS; Jeong J; Kim SJ; Jin W
Oncotarget; 2015 Nov; 6(37):40158-71. PubMed ID: 26515594
[TBL] [Abstract][Full Text] [Related]
29. Tropomyosin-related kinase B mediated signaling contributes to the induction of malignant phenotype of gallbladder cancer.
Kawamoto M; Onishi H; Ozono K; Yamasaki A; Imaizumi A; Kamakura S; Nakano K; Oda Y; Sumimoto H; Nakamura M
Oncotarget; 2017 May; 8(22):36211-36224. PubMed ID: 28423707
[TBL] [Abstract][Full Text] [Related]
30. Advances in Regulating Tumorigenicity and Metastasis of Cancer Through TrkB Signaling.
Zou W; Hu X; Jiang L
Curr Cancer Drug Targets; 2020; 20(10):779-788. PubMed ID: 32748747
[TBL] [Abstract][Full Text] [Related]
31. Neurotrophin receptor TrkB promotes lung adenocarcinoma metastasis.
Sinkevicius KW; Kriegel C; Bellaria KJ; Lee J; Lau AN; Leeman KT; Zhou P; Beede AM; Fillmore CM; Caswell D; Barrios J; Wong KK; Sholl LM; Schlaeger TM; Bronson RT; Chirieac LR; Winslow MM; Haigis MC; Kim CF
Proc Natl Acad Sci U S A; 2014 Jul; 111(28):10299-304. PubMed ID: 24982195
[TBL] [Abstract][Full Text] [Related]
32. Cyclic-AMP response element-based signaling assays for characterization of Trk family tyrosine kinases modulators.
Zhang J; Chen D; Gong X; Ling H; Zhang G; Wood A; Heinrich J; Cho S
Neurosignals; 2006-2007; 15(1):26-39. PubMed ID: 16837782
[TBL] [Abstract][Full Text] [Related]
33. IDH-mutant astrocytoma with an evolutional progression to CDKN2A/B homozygous deletion and NTRK fusion during recurrence: A case report.
Kirishima M; Akahane T; Higa N; Suzuki S; Ueno S; Yonezawa H; Uchida H; Hanaya R; Yoshimoto K; Shimajiri S; Kitazono I; Tanimoto A
Pathol Res Pract; 2022 Nov; 239():154163. PubMed ID: 36265224
[TBL] [Abstract][Full Text] [Related]
34. Brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from chemotherapy-induced apoptosis via phosphatidylinositol 3'-kinase pathway.
Jaboin J; Kim CJ; Kaplan DR; Thiele CJ
Cancer Res; 2002 Nov; 62(22):6756-63. PubMed ID: 12438277
[TBL] [Abstract][Full Text] [Related]
35. Astrocyte-specific expression of CDK4 is not sufficient for tumor formation, but cooperates with p53 heterozygosity to provide a growth advantage for astrocytes in vivo.
Huang ZY; Baldwin RL; Hedrick NM; Gutmann DH
Oncogene; 2002 Feb; 21(9):1325-34. PubMed ID: 11857076
[TBL] [Abstract][Full Text] [Related]
36. Identifying patients with NTRK fusion cancer.
Solomon JP; Benayed R; Hechtman JF; Ladanyi M
Ann Oncol; 2019 Nov; 30 Suppl 8():viii16-viii22. PubMed ID: 32223934
[TBL] [Abstract][Full Text] [Related]
37. Multiplex quantitative assays indicate a need for reevaluating reported small-molecule TrkB agonists.
Boltaev U; Meyer Y; Tolibzoda F; Jacques T; Gassaway M; Xu Q; Wagner F; Zhang YL; Palmer M; Holson E; Sames D
Sci Signal; 2017 Aug; 10(493):. PubMed ID: 28831019
[TBL] [Abstract][Full Text] [Related]
38. PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo.
Dai C; Celestino JC; Okada Y; Louis DN; Fuller GN; Holland EC
Genes Dev; 2001 Aug; 15(15):1913-25. PubMed ID: 11485986
[TBL] [Abstract][Full Text] [Related]
39. Mitogenic signaling and the relationship to cell cycle regulation in astrocytomas.
Besson A; Yong VW
J Neurooncol; 2001 Feb; 51(3):245-64. PubMed ID: 11407596
[TBL] [Abstract][Full Text] [Related]
40. p19(ARF) /p14(ARF) controls oncogenic functions of signal transducer and activator of transcription 3 in hepatocellular carcinoma.
Schneller D; Machat G; Sousek A; Proell V; van Zijl F; Zulehner G; Huber H; Mair M; Muellner MK; Nijman SM; Eferl R; Moriggl R; Mikulits W
Hepatology; 2011 Jul; 54(1):164-72. PubMed ID: 21452288
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
